{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T13:10:02Z","timestamp":1750943402968,"version":"3.41.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologie"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00117-025-01459-5","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T12:19:30Z","timestamp":1748434770000},"page":"508-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Staging und Therapieansprechen mit radiologischen und nuklearmedizinischen Verfahren bei Non-Hodgkin-Lymphomen (NHL)","Staging and treatment response assessment with radiological and nuclear medicine approaches for non-Hodgkin lymphomas"],"prefix":"10.1007","volume":"65","author":[{"given":"Christian","family":"Neelsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz-Peter","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Dimitrakopoulou-Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Sachpekidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"1459_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio\u00a0R, Amador\u00a0C, Anagnostopoulos\u00a0I et\u00a0al (2022) The 5th\u00a0edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720\u20131748","journal-title":"Leukemia"},{"key":"1459_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/hon.2676","volume":"38","author":"D Albano","year":"2020","unstructured":"Albano\u00a0D, Bruno\u00a0A, Patti\u00a0C et\u00a0al (2020) Whole-body magnetic resonance imaging (WB-MRI) in lymphoma: state of the art. Hematol Oncol 38:12\u201321","journal-title":"Hematol Oncol"},{"key":"1459_CR3","doi-asserted-by":"crossref","unstructured":"Albano D, Dondi F, Bertagna F et\u00a0al (2022) The role of ((68)ga)ga-Pentixafor PET\/CT or PET\/MRI in lymphoma: a\u00a0systematic review. Cancers: 14","DOI":"10.3390\/cancers14153814"},{"key":"1459_CR4","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/neuonc\/noab020","volume":"23","author":"RF Barajas","year":"2021","unstructured":"Barajas\u00a0RF, Politi\u00a0LS, Anzalone\u00a0N et\u00a0al (2021) Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG). Neuro Oncol 23:1056\u20131071","journal-title":"Neuro Oncol"},{"key":"1459_CR5","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington\u00a0SF, Mikhaeel\u00a0NG, Kostakoglu\u00a0L et\u00a0al (2014) Role of imaging in the staging and response assessment of lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J\u00a0Clin Oncol 32:3048\u20133058","journal-title":"J Clin Oncol"},{"key":"1459_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40658-021-00373-8","volume":"8","author":"NA Bebbington","year":"2021","unstructured":"Bebbington\u00a0NA, Jorgensen\u00a0T, Dupont\u00a0E et\u00a0al (2021) Validation of CARE kV automated tube voltage selection for PET-CT: PET quantification and CT radiation dose reduction in phantoms. EJNMMI Phys 8:29","journal-title":"EJNMMI Phys"},{"key":"1459_CR7","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1200\/JCO.2010.32.5225","volume":"29","author":"BD Cheson","year":"2011","unstructured":"Cheson\u00a0BD (2011) Role of functional imaging in the management of lymphoma. J\u00a0Clin Oncol 29:1844\u20131854","journal-title":"J Clin Oncol"},{"key":"1459_CR8","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/blood-2016-05-718528","volume":"128","author":"BD Cheson","year":"2016","unstructured":"Cheson\u00a0BD, Ansell\u00a0S, Schwartz\u00a0L et\u00a0al (2016) Refinement of the Lugano classification lymphoma response criteria in the era of immunomodulatory therapy. Blood 128:2489\u20132496","journal-title":"Blood"},{"key":"1459_CR9","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson\u00a0BD, Fisher\u00a0RI, Barrington\u00a0SF et\u00a0al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification. J\u00a0Clin Oncol 32:3059\u20133068","journal-title":"J Clin Oncol"},{"key":"1459_CR10","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson\u00a0BD, Horning\u00a0SJ, Coiffier\u00a0B et\u00a0al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J\u00a0Clin Oncol 17:1244","journal-title":"J Clin Oncol"},{"key":"1459_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson\u00a0BD, Pfistner\u00a0B, Juweid\u00a0ME et\u00a0al (2007) Revised response criteria for malignant lymphoma. J\u00a0Clin Oncol 25:579\u2013586","journal-title":"J Clin Oncol"},{"key":"1459_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121641","author":"A Dimitrakopoulou-Strauss","year":"2024","unstructured":"Dimitrakopoulou-Strauss\u00a0A, Pan\u00a0L, Sachpekidis\u00a0C (2024) Non-((18)F)FDG PET-Radiopharmaceuticals in Oncology. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph17121641","journal-title":"Pharmaceuticals"},{"key":"1459_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","volume":"32","author":"B Eichhorst","year":"2021","unstructured":"Eichhorst\u00a0B, Robak\u00a0T, Montserrat\u00a0E et\u00a0al (2021) Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 32:23\u201333","journal-title":"Ann Oncol"},{"key":"1459_CR14","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico\u00a0M, Bellei\u00a0M, Marcheselli\u00a0L et\u00a0al (2009) Follicular lymphoma international prognostic index 2: a\u00a0new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J\u00a0Clin Oncol 27:4555\u20134562","journal-title":"J Clin Oncol"},{"key":"1459_CR15","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1002\/hem3.89","volume":"8","author":"AJM Ferreri","year":"2024","unstructured":"Ferreri\u00a0AJM, Illerhaus\u00a0G, Doorduijn\u00a0JK et\u00a0al (2024) Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Hemasphere 8:e89","journal-title":"Hemasphere"},{"key":"1459_CR16","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek\u00a0M, Cheson\u00a0BD, Catovsky\u00a0D et\u00a0al (2018) iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 131:2745\u20132760","journal-title":"Blood"},{"key":"1459_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2967\/jnumed.121.262134","volume":"63","author":"X Jin","year":"2022","unstructured":"Jin\u00a0X, Wei\u00a0M, Wang\u00a0S et\u00a0al (2022) Detecting Fibroblast activation proteins in lymphoma using (68)ga-FAPI PET\/CT. J\u00a0Nucl Med 63:212\u2013217","journal-title":"J Nucl Med"},{"key":"1459_CR18","doi-asserted-by":"publisher","first-page":"iv41","DOI":"10.1093\/annonc\/mdy146","volume":"29","author":"E Kastritis","year":"2018","unstructured":"Kastritis\u00a0E, Leblond\u00a0V, Dimopoulos\u00a0MA et\u00a0al (2018) Waldenstrom\u2019s macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv41\u2013iv50","journal-title":"Ann Oncol"},{"key":"1459_CR19","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.rcl.2004.08.008","volume":"42","author":"R Kumar","year":"2004","unstructured":"Kumar\u00a0R, Maillard\u00a0I, Schuster\u00a0SJ et\u00a0al (2004) Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas. Radiol Clin North Am 42:1083\u20131100","journal-title":"Radiol Clin North Am"},{"key":"1459_CR20","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, Awmf) S3-Leitlinie Diagnostik, Therapie und Nachsorge f\u00fcr Patient*innen mit einer chronischen lymphatischen Leuk\u00e4mie (CLL), Langversion 2.0, 2024, AWMF-Registernummer: 018-032OL https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/CLL\/Version_2\/LL_CLL_Langversion_2.0.pdf. In:"},{"key":"1459_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.7150\/thno.48620","volume":"11","author":"ME Mayerhoefer","year":"2021","unstructured":"Mayerhoefer\u00a0ME, Raderer\u00a0M, Lamm\u00a0W et\u00a0al (2021) CXCR4 PET imaging of mantle cell lymphoma using ((68)Ga)Pentixafor: comparison with ((18)F)FDG-PET. Theranostics 11:567\u2013578","journal-title":"Theranostics"},{"key":"1459_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00117-020-00669-3","volume":"60","author":"T Mokry","year":"2020","unstructured":"Mokry\u00a0T, Flechsig\u00a0P, Dietrich\u00a0S et\u00a0al (2020) Diagnostic imaging of malignant lymphomas. Radiologe 60:445\u2013458","journal-title":"Radiologe"},{"key":"1459_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood.2021012057","volume":"140","author":"EA Olsen","year":"2022","unstructured":"Olsen\u00a0EA, Whittaker\u00a0S, Willemze\u00a0R et\u00a0al (2022) Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood 140:419\u2013437","journal-title":"Blood"},{"key":"1459_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1470-2045(08)70078-0","volume":"9","author":"M Pfreundschuh","year":"2008","unstructured":"Pfreundschuh\u00a0M, Ho\u00a0AD, Cavallin-Stahl\u00a0E et\u00a0al (2008) Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study. Lancet Oncol 9:435\u2013444","journal-title":"Lancet Oncol"},{"key":"1459_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3322\/caac.21330","volume":"66","author":"M Raderer","year":"2016","unstructured":"Raderer\u00a0M, Kiesewetter\u00a0B, Ferreri\u00a0AJM (2016) Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin 66:152\u2013171","journal-title":"CA Cancer J. Clin."},{"key":"1459_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2967\/jnumed.122.264106","volume":"64","author":"F Ricard","year":"2023","unstructured":"Ricard\u00a0F, Cheson\u00a0B, Barrington\u00a0S et\u00a0al (2023) Application of the Lugano classification for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: the PRoloG consensus initiative (part\u00a01\u2014clinical). J\u00a0Nucl Med 64:102\u2013108","journal-title":"J Nucl Med"},{"key":"1459_CR27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.medcli.2010.10.031","volume":"137","author":"B Rodriguez-Vigil Junco","year":"2011","unstructured":"Rodriguez-Vigil Junco\u00a0B, Gomez\u00a0LN, Pinilla Fernandez\u00a0I et\u00a0al (2011) Non-Hodgkin\u2019s lymphoma staging: a\u00a0prospective study of the value of positron emission tomography\/computed tomography (PET\/CT) versus PET and CT. Med Clin 137:383\u2013389","journal-title":"Med Clin"},{"key":"1459_CR28","unstructured":"S3-Leitlinienprogramm Onkologie Der Arbeitsgemeinschaft Der Wissenschaftlichen Medizinischen Fachgesellschaften E. V. (Awmf) DKEVD, Und Der Stiftung Deutsche Krebshilfe (Dkh) (2020) Leitlinie zur Diagnostik und Therapie des diffusen gro\u00dfzelligen B\u2011Zell-Lymphoms (DLBCL). In: Prof. Dr. Peter Borchmann PDNSKi (ed)"},{"key":"1459_CR29","doi-asserted-by":"crossref","unstructured":"Triumbari EKA, Morland D, Laudicella R et\u00a0al (2022) Clinical applications of immuno-PET in Lymphoma: a\u00a0systematic review. Cancers 14:","DOI":"10.3390\/cancers14143488"},{"key":"1459_CR30","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.2147\/OTT.S148189","volume":"11","author":"D Wang","year":"2018","unstructured":"Wang\u00a0D, Huo\u00a0Y, Chen\u00a0S et\u00a0al (2018) Whole-body MRI versus (18)F-FDG PET\/CT for pretherapeutic assessment and staging of lymphoma: a\u00a0meta-analysis. Onco Targets Ther 11:3597\u20133608","journal-title":"Onco Targets Ther"},{"key":"1459_CR31","doi-asserted-by":"publisher","first-page":"iv30","DOI":"10.1093\/annonc\/mdy133","volume":"29","author":"R Willemze","year":"2018","unstructured":"Willemze\u00a0R, Hodak\u00a0E, Zinzani\u00a0PL et\u00a0al (2018) Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv30\u2013iv40","journal-title":"Ann Oncol"},{"key":"1459_CR32","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","volume":"28","author":"A Younes","year":"2017","unstructured":"Younes\u00a0A, Hilden\u00a0P, Coiffier\u00a0B et\u00a0al (2017) International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol 28:1436\u20131447","journal-title":"Ann Oncol"},{"key":"1459_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.semnuclmed.2022.11.001","volume":"53","author":"L Zanoni","year":"2023","unstructured":"Zanoni\u00a0L, Bezzi\u00a0D, Nanni\u00a0C et\u00a0al (2023) PET\/CT in non-hodgkin lymphoma: an update. Semin Nucl Med 53:320\u2013351","journal-title":"Semin Nucl Med"},{"key":"1459_CR34","doi-asserted-by":"publisher","first-page":"109793","DOI":"10.1016\/j.ejrad.2021.109793","volume":"141","author":"L Zanoni","year":"2021","unstructured":"Zanoni\u00a0L, Mattana\u00a0F, Calabro\u00a0D et\u00a0al (2021) Overview and recent advances in PET\/CT imaging in lymphoma and multiple myeloma. Eur J Radiol 141:109793","journal-title":"Eur J Radiol"},{"key":"1459_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","volume":"31","author":"E Zucca","year":"2020","unstructured":"Zucca\u00a0E, Arcaini\u00a0L, Buske\u00a0C et\u00a0al (2020) Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 31:17\u201329","journal-title":"Ann Oncol"}],"container-title":["Die Radiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-025-01459-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-025-01459-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-025-01459-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:29:37Z","timestamp":1750940977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-025-01459-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1459"],"URL":"https:\/\/doi.org\/10.1007\/s00117-025-01459-5","relation":{},"ISSN":["2731-7048","2731-7056"],"issn-type":[{"type":"print","value":"2731-7048"},{"type":"electronic","value":"2731-7056"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"22 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Neelsen, A.\u00a0Mohammad, H.-P.\u00a0Schlemmer, A.\u00a0Dimitrakopoulou-Strauss und C.\u00a0Sachpekidis geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}